AAIC 2020

Quanterix Product Theater Presentation:

Novel Simoa® p-tau181 Blood Immunoassay to Support Research, Therapeutics Development and Clinical Care of Alzheimer's Disease

Please complete the form to access the video.

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy.  In addition, you agree to receive information regarding Quanterix products and services.  You will be able to unsubscribe at any time.

Follow Us!


Learn more about groundbreaking Simoa technology!

Tatiana Plavina, PhD, Quanterix VP, Clinical Strategy, will take a deep dive into the new Simoa p-tau181 blood immunoassay and provide a first look at our newest multiplex neurology kit targeted for Alzheimer's research!